Treating muscle loss in older adults

What we are studying

The purpose of this study is to see if an investigational medicine called BIO101 could be used to treat sarcopenia, including sarcopenic obesity, in the elderly. Sarcopenia is characterized by a progressive loss of muscle mass and decreased muscle capacity, which appears around age fifty and involves an increased risk of falls and fractures.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 65+

Eligibility Criteria

  • People with symptoms of sarcopenia (loss of muscle tissue as a natural part of the aging process)

What is involved

  • Informed Consent Review
  • Review of Medical History
  • Physical Examinations
  • Phone Calls and/or Emails
  • Study Visits and Consultations
  • Surveys/Questionnaires
  • Laboratory and Imaging Tests
  • Specimen Sample Collection
  • Use of Study Treatments or Placebo


Yes. The study team will provide more information.

Contact Information

Study Coordinator
Stacy Woodliff
(336) 716-2040
Principal Investigator
Stephen Kritchevsky, PhD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.